Operators reach ProphetX's exchange through Plaee's technology stack — with white label trading interface, CRM, and risk controls built-in

NEW YORK, Sept. 30, 2026 /PRNewswire/ -- ProphetX, America's first federally regulated sports-native prediction market, today announced a strategic technology partnership with Plaee, a leading prediction-native, technology provider serving prediction market distribution operators and trading platforms. The partnership gives ProphetX a scalable path to onboard new distribution operators avoiding custom builds for each one.

Through Plaee's single integration operators connect to ProphetX equipped with the full stack required to launch and grow a durable prediction markets distribution business. Plaee's solution allows operators to add prediction markets to their existing product line, or launch a new stand-alone prediction market distribution channel within weeks, all with their existing team. In addition to exchange connectivity, Plaee's platform includes Prediction Trader, its white label trading access interface, and PlaeeOS, its CRM, personalization and monetization engine.

"Plaee has built real infrastructure for distribution operators who want to offer access to prediction markets without taking on the regulatory and tech build themselves. Pairing that with ProphetX's exchange gives those operators a compliant, ready-to-go path to offer sports event contracts to their users."

  — Jake Benzaquen, Co-Founder and CCO, ProphetX    

"Plaee was built to remove the three biggest hurdles for operators: Product development, access to liquidity and time-to-market. ProphetX brings a proven, CFTC-compliant exchange purpose-built for sports to our stack. Operators will immediately benefit from ProphetX's breadth and depth of markets, while ProphetX will enjoy greater distribution; all from our single integration."

  — Leon Okun, Co-Founder and CEO, Plaee

A Dedicated B2B Partner for Prediction Markets

ProphetX is building the regulated infrastructure that lets platforms like Plaee offer prediction markets access natively to operators and audiences they already serve. Through its Partner Distribution Program, ProphetX handles clearing, custody, market operations, and the core regulatory and operational functions of operating a CFTC-regulated exchange, allowing partners to focus on their products and operator relationships. For Plaee, that means its operator clients can access a regulated exchange infrastructure without needing to become a DCM or DCO themselves.

Partnership Details

Under the agreement, ProphetX will be integrated as a regulated exchange within Plaee's Prediction Trader interface and PlaeeOS backend, available to Plaee's operator clients as part of their existing platform. The integration is currently in Beta.

ABOUT PROPHETX

Founded in 2018, ProphetX is America's first sports-native prediction market. The company is a regulated U.S. exchange for event-driven contracts, built on a sports-focused foundation and designed to expand across a broad range of event markets. Its mission is to create the world's most trusted and innovative marketplace where anyone can participate in event outcomes.

ABOUT PLAEE

Plaee is the first prediction-native technology provider offering a scalable, white-label platform that combines prediction market trading infrastructure and robust CRM and personalization capabilities. Its product suite — including Prediction Trader and PlaeeOS — gives operators the tools to launch, customize, and manage prediction markets without building the underlying technology.

MEDIA CONTACT

ProphetX: ProphetX Newsroom | [email protected]

Plaee: Plaee Media | [email protected]

SOURCE ProphetX

Share this article

Fairfield County Entrepreneur Launches Concierge Service Business Helping Residents Discover the Value of Forgotten Coins, Jewelry and Precious Metals

Liberty Ridge Coins & Bullion brings private, pressure-free evaluations directly to homes throughout Western Connecticut and the surrounding New York region. The company recently helped a customer discover two coins valued at $60,000

RIDGEFIELD, Conn., Sept. 30, 2026 /PRNewswire/ -- As Fairfield County residents are getting organized for Fall and the holidays, many are also tackling long-overdue cleaning and organizing projects—and discovering forgotten coin collections, inherited jewelry and precious metals tucked away in drawers, safes and attics.

For Ridgefield resident and longtime collector Jay Goodman, those discoveries inspired the launch of Liberty Ridge Coins & Bullion, a personalized -style business offering private, in-home evaluations of coin collections, jewelry, bullion, precious metals and estate collections throughout Fairfield County and surrounding communities in New York.

Founded in 2025, Liberty Ridge Coins & Bullion was created to provide homeowners and families with an educational, convenient and pressure-free way to understand what their collections may be worth.

"People often inherit a collection or jewelry from a parent or grandparent and have no idea what they have," said Goodman. "They may have questions about whether something is valuable, where it came from, or what their options are. My goal is to make the evaluation process comfortable, educational and completely pressure-free."

Goodman recently met with a customer who had inherited a coin collection and uncovered two significant rarities: The 1907 High Relief Saint-Gaudens $20 gold coin, with only 12,367 struck, and a rare 1801 $10 Draped Bust gold coin were recently graded by PCGS at the ANA coin show in Pittsburgh. The coins received grades of MS64 and AU53, respectively, and are worth roughly $60,000 in their certified condition. Exceptional examples of these coins can be worth more than $1.2 million combined - showing how proper identification and preservation can make a life-changing difference in the value of an old coin collection.

Goodman's passion for collecting and decades of experience in the coin and precious-metals market allow him to work with clients ranging from first-time sellers to experienced collectors. Evaluations can include individual coins as well as complete estate collections.

A Personalized Approach to Collectibles

Liberty Ridge Coins & Bullion offers private, appointment-only consultations either in a client's home or at a local meeting location. Professional testing equipment is used to authenticate precious metals and assist in evaluating items.

Services include evaluation, purchase and consultation for:

- Gold, silver, platinum and palladium

- U.S. and international coins

- Rare and certified coins

- Paper currency

- Jewelry and scrap gold

- Estate and inherited collections

- Bullion

- Collection acquisitions

The company's process begins with a complimentary initial consultation and professional review of the items. Goodman explains the findings and current market values, answers questions, and discusses available options. There is never an obligation to sell.

"Education is a major part of what we do," Goodman said. "I want people to understand what they have and why it may or may not have value so they can make their own informed decision about what to do next."

Turning Forgotten Items into Informed Decisions

Goodman says inherited collections are among the items that frequently prompt homeowners to seek an evaluation. Families may have boxes of coins, jewelry or bullion that have been sitting untouched for years simply because they do not know where to begin.

For homeowners undertaking summer cleaning projects, Goodman encourages them not to automatically discard or sell items before having them properly examined.

"Before you clean, throw away or sell an old collection, take the time to find out what you're actually holding," Goodman said. "Something that looks ordinary can sometimes warrant a closer look."

Liberty Ridge Coins & Bullion serves clients throughout Fairfield and Litchfield counties, including Ridgefield, Redding, Weston, Wilton, Newtown and Danbury, as well as Westchester County and the Hudson Valley in New York. Remote evaluation and purchasing services are also available for clients nationwide.

Private appointments available by request.

All evaluations are informal market assessments intended for buying, selling or educational purposes. Liberty Ridge Coins & Bullion does not provide written insurance, estate, tax or legal appraisals. Information provided is educational in nature and should not be construed as financial, investment or legal advice.

Media Contact:

Merideth Fanning Gilmor, Modern Global Communications

917.860.5792

[email protected]

About Liberty Ridge Coins & Bullion

Founded in 2025 by Ridgefield, Connecticut resident and longtime collector Jay Goodman, Liberty Ridge Coins & Bullion provides trusted precious-metals and coin evaluation services to collectors, investors and families throughout Western Connecticut and the surrounding New York region.

The company's mission is to help individuals and families understand the history, significance and potential value of their coins, jewelry and precious metals through honest guidance, expertise and personalized service.

SOURCE Liberty Ridge Coins & Bullion

Share this article

If approved, tabelecleucel will be the first FDA-authorized treatment for relapsed/refractory EBV+ PTLD patients whose survival is measured in only a few weeks to months following failure of initial therapy

SECAUCUS, N.J., Sept. 30, 2026 /PRNewswire/ -- Pierre Fabre Pharmaceuticals Inc. (PFP) announces the resubmission of the tabelecleucel Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) with a proposed indication as monotherapy for the treatment of adult and pediatric patients 2 years of age and older with Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have received at least one prior therapy.

"PFP remains committed to working with the FDA to advance treatment options for people living with EBV+ PTLD who after undergoing a potentially life-saving solid organ or hematopoietic cell transplant suddenly face yet another life-threatening illness, cancer," said Adriana Herrera, Chief Executive Officer of PFP, the Laboratoires Pierre Fabre Pharmaceutical subsidiary in the U.S. "These patients are waiting for an FDA-approved treatment as their survival after failure of initial therapy is measured in only weeks to a few months."

PFP resubmitted the BLA based on April 2026 Type A meeting alignment with the FDA. The submission includes an updated dataset with additional patients and longer follow up from the ongoing pivotal Phase 3 single arm ALLELE study of tabelecleucel in adults and children two years of age and older with relapsed/refractory EBV+ PTLD following hematopoietic cell transplant (HCT) or solid organ transplant (SOT). The resubmission also includes additional supplemental data from expanded access programs, a separate clinical study, and commercial experience in Europe.

Tabelecleucel is an allogeneic, off the shelf, EBV-specific T-cell immunotherapy which is designed to target and attack EBV-infected cells. It was granted marketing authorization under the brand name EBVALLO™ in December 2022 by the European Commission. Marketing authorization was also granted by the Medicines and Healthcare Products Regulatory Agency in the United Kingdom in May 2023 and by Swissmedic in Switzerland in May 2024. In the U.S., tabelecleucel is investigational and has not yet been approved by the FDA. It may be available to eligible patients through clinical trials and expanded access programs.

About EBV+ PTLD

EBV+ PTLD is an ultra-rare, acute, and potentially deadly hematologic malignancy that occurs after transplantation when patient T-cell immune responses are compromised by immunosuppression. It can impact patients who have undergone SOT or allogeneic HCT. SOT patients have a life-long risk of contracting the disease. Poor median survival of 3 weeks and 4.1 months for HCT and SOT, respectively, is reported in EBV+ PTLD patients for whom initial treatment failed, underscoring the significant need for new therapeutic options.

About Pierre Fabre Pharmaceuticals and Laboratoires Pierre Fabre

The mission of PFP is to deliver breakthrough therapies in oncology and rare diseases to patient populations with high unmet needs and limited treatment options. Our belief is that every time we care for a single person, we make the whole world better.

PFP is the US pharmaceutical subsidiary of Laboratoires Pierre Fabre , a foundation-owned company with seven decades of impact. Laboratoires Pierre Fabre is a global healthcare company, established in 43 countries, with over 10,000 employees, and with products distributed in 120 territories across the globe.

The Laboratoires Pierre Fabre foundation ownership enhances the ability of the company to create long-term value for patients. Partnerships and acquisitions drive its innovative precision treatment pipeline and are enabled by the unique corporate structure.

Building on the legacy of Laboratoires Pierre Fabre , innovation is the life blood of PFP, and patient experience drives everything the company does. PFP aspires to design and develop therapeutic solutions inspired by patients and healthcare professionals; draw on science and nature as perpetual sources of inspiration; develop long-term partnerships with researchers and innovators worldwide; and place pharmaceutical ethics and climate transition at the heart of our action.

Pierre Fabre Pharmaceuticals has therapies in development for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), NRAS-mutant melanoma, non-small cell lung cancer with mutation or amplification of MET, and X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED). Pierre Fabre Pharmaceuticals is headquartered in Secaucus, NJ.

For more information, visit www.pierrefabrepharmaceuticals.com, www.pierre-fabre.com, @Pierre Fabre Oncology.

SOURCE Pierre Fabre Pharmaceuticals

Share this article

The company will scale toward producing the first pharmaceuticals made in space for patients on Earth.

EL SEGUNDO, Calif., Sept. 30, 2026 /PRNewswire/ -- Varda Space Industries announced a Series D fundraising round today, bringing the total amount of capital raised by the microgravity-enabled life sciences company to $598 million. The $251 million fundraise was led by Lux Capital and Natural Capital, with participation from Founders Fund, Khosla Ventures, Caffeinated Capital, General Catalyst, 8090 Industries, Giant Step, and Also Capital.

The first product made in space for use on Earth will be a pharmaceutical. Due to the absence of gravity, materials such as the active pharmaceutical ingredients in medicines can be crystallized in ways that would be impossible on Earth, enabling novel drug formulations that can benefit patients.

The company is transforming in-space pharmaceutical processing to be a normal, reliable part of the drug development pipeline.

"In-space manufacturing means building what space needs, in space, and making what Earth can't. Varda is making life-saving drugs impossible to make under gravity. It's the first and only company delivering a real cadence of launches and re-entries, with capsules built to manufacture the impossible and return it home," said Shahin Farshchi, Partner at Lux Capital.

Building Toward the First Medicine Made in Space

Decades of ISS research have demonstrated microgravity's potential to produce drug formulations that are impossible to achieve on Earth, and Varda is now the only company with the launch cadence, reentry capability, and pharmaceutical science team to bring that potential to market.

"We started Varda with the conviction that the first product manufactured in space and consumed on Earth would be a pharmaceutical," said Varda co-founder and President Delian Asparouhov. "This round gives us the resources to increase our cadence, deepen our pharmaceutical partnerships, get closer to delivering the first medicine made in space."

Since its first mission launched in 2023, Varda has rapidly increased its flight cadence, completing six successful reentry missions with over a dozen more launches and reentries planned through 2028. Varda's W-Series vehicles, which reach Mach 25 on their reentry from orbit, offer government and commercial partners a reliable, repeatable, and economical way to return materials and data from space to Earth.

As launch cadence across the industry continues to increase, the ability to bring things back will become as foundational as the ability to send them up.

About Varda

Varda Space Industries is building the infrastructure for a thriving orbital economy, from in-orbit pharmaceutical processing to reliable and economical hypersonic reentry capsules. The company operates out of El Segundo, California with office and industrial production space and has office space in Washington, D.C. and Huntsville, Alabama. Follow Varda on X (@vardaspace), Instagram (@vardaspaceindustries), and LinkedIn.

Alex Pearlman, Head of Communications and Marketing: [email protected]

SOURCE Varda Space Industries Inc.

Share this article

BLOOMINGTON, Minn. and PURCELLVILLE, Va., Sept. 30, 2026 /PRNewswire/ -- White Pine Capital® announced today it has been named to the celebrated PSN Top Guns List of best performing separate accounts, managed accounts, and managed ETF strategies for Q2 2026 in two distinct universes.

White Pine Capital's Small Cap strategy ranked first in the PSN US Core Universe category out of 697 products and 271 firms for the one-year, and three-year periods ended second quarter 2026 (see performance). Tim Madey, Chief Investment Officer and lead manager on the strategy, said, "It's gratifying to help our clients meet or exceed their investment objectives. Our investment team is humbled by this recognition."

In addition, White Pine Capital had the top ranked returns for the one-year and three-year periods in the PSN Small Cap Core Universe ending second quarter 2026 (see performance). The PSN Small Cap Core Universe is comprised of 151 products and 123 firms. The highly anticipated PSN Top Guns list, published by YCharts, remains one of the most important references for investors and asset managers.

White Pine Capital's Small Cap strategy has a 26-year track record and has been recognized as a PSN Top Gun award winner in seventeen quarterly periods since 2018. The firm's investment team includes Tim Madey, Charlie Bellows, Mike Wallace, and new team member Randy Scherago.

"On behalf of YCharts, I want to extend my congratulations to this quarter's PSN Top Guns winners for their outstanding performance during a particularly challenging period for investment managers," says President and CEO of YCharts, Sean Brown. "The second quarter tested even seasoned professionals, as markets shifted from early optimism to a more challenging environment that caught many portfolios off guard. What distinguishes these winners is their disciplined approach and ability to navigate uncertainty with conviction. They positioned portfolios with precision and delivered standout results when it counted most."

Through a combination of PSN's proprietary performance screens, the PSN Top Guns List awards products in six proprietary categories in over 75 universes based on continued performance over time. White Pine Capital's Small Cap strategy earned a PSN Top Guns award, meaning our strategy had one of the top ten returns for the respective period(s) in the respective strategies.

The complete list of PSN Top Guns and an overview of the methodology can be located at https://psn.fi.informais.com/PSNTopGuns/topguns_zephyr.asp

With offices in Bloomington, Minnesota and Purcellville, Virginia, White Pine Capital is an independent registered investment advisor with the Securities and Exchange Commission since 2000. White Pine Capital is co-managed by the firm's President, Michael Wallace, CFA, and Chief Investment Officer, Timothy Madey. White Pine Capital provides fee-based discretionary investment advisory services to high-net-worth, family office and institutional clients.

About PSN

For more than four decades, PSN has been a top resource for investment professionals. Over 2,800 firms, 285 universes, and more than 21,000 products comprise the PSN SMA database showing asset breakdowns, compliance, key personnel, ownership diversity, ESG, business objectives and strategy, style, fees, GIC sectors, fixed income ranges and full holdings. Unique to PSN is its robust historical database of over 40 years of data including net and gross-of-fee returns.

About YCharts

YCharts is a top-ranked investment research and client engagement platform that enables financial advisors and asset managers to make smarter investment decisions and better communicate with clients. Trusted by over 15,000 financial professionals and recognized as the Investment Research market leader by Kitces research, YCharts delivers intuitive tools for security research, portfolio construction, AI-enabled proposals, client communication, and market monitoring. In the 2026 T3 / Inside Information Technology Survey, YCharts was named a "Software All-Star" across five categories. YCharts also earned a 2025 Wealthie Award for its AI Chat feature and has been recognized ten consecutive times on the Inc. 5000 list of America's fastest-growing private companies. Learn more at www.ycharts.com.

SOURCE White Pine Capital

Share this article

HFS replaces its flagship Horizons assessments with Services-as-Software™ Star Ratings built on more than 400 enterprise client verdicts, zero vendor influence and no analyst scoring, ending a decades-old industry model in which provider rankings were shaped by briefing decks and vendor relationships rather than delivery reality

BOSTON, Sept. 30, 2026 /PRNewswire/ -- HFS Research today launched HFS Services-as-Software™ (SaS) Stars Ratings and retired HFS Horizons, its flagship analyst-scored provider assessment. SaS Star evaluations rate providers purely on how enterprise clients experience their capabilities in live delivery and whether they help those enterprises achieve real business outcomes. Every rating comes from enterprise clients running live engagements; providers submit no scoring inputs and cannot influence the ratings in any way, and HFS analysts do not score providers.

The move is a deliberate break from the analyst industry's long-standing provider rating model, in which rankings are assembled from vendor briefings, RFI responses, and vendor-selected references, then scored by analysts whose judgments are inevitably shaped by their relationships with the providers they evaluate. That model has served providers well and enterprises poorly, rewarding briefing power and marketing scale over what actually happens once the work is live. The SaS Stars methodology replaces pitch with proof, giving enterprises a current view of where providers create value, where friction persists, and includes a customizable dashboard that shows how the field changes when enterprises apply their own priorities.

From this point forward, HFS provider ratings will be driven by enterprise client experience rather than any subjective scoring. HFS will continue to design the methodology, test the evidence, provide market context, and explain what the findings mean, but providers do not determine the inputs and analysts do not determine the scores.

"The analyst industry has spent two decades ranking providers on briefing decks, RFI responses, and analyst opinion, and everyone in the market knows how much those rankings are shaped by vendor relationships. Horizons was part of that model, and we are retiring it because enterprises deserve better," said Phil Fersht, Founder, CEO, and Chief Analyst, HFS Research. "SaS Stars removes the analyst and the vendor from the scoring entirely. The only people who rate a provider are the enterprise clients living with the work, and we believe that is the only credible basis for provider evaluation from here on."

A provider rating built from lived enterprise client experience

SaS Stars Ratings are built around five dimensions that distinguish Services-as-Software delivery from legacy services: AI-first delivery, proprietary IP and codified expertise, investment velocity, outcome-aligned commercials, and production scalability. Only current enterprise clients rate a provider. Participants must own or govern the engagement, have at least 12 months of experience with it, and be independent of the provider being rated. Ratings are weighted by engagement scope, tenure, and deal size and confidence-adjusted to reduce the impact of thin or divided samples. Providers cannot buy inclusion, influence their scores, select the client references, or submit scoring inputs.

What changes with SaS Stars

- 100% enterprise client-sourced ratings, zero vendor influence: Scores come from enterprise clients running live engagements, not vendor briefings, RFIs, or vendor-selected references.

- An enterprise decision tool, not a static scoreboard: Enterprises can re-weight the criteria to their own priorities and re-rank the provider field to build a more relevant shortlist for their own context.

- A broader field of view: The model gives specialists and challengers a fairer chance to be seen alongside established firms, based on who enterprises use and how those clients experience delivery - not provider market presence or briefing power.

- Current evidence at market speed: The model is built in weeks rather than the roughly six-month cycle common to traditional provider studies.

- Context without analyst scoring: HFS analysts design the methodology, interpret the market evidence, and identify implications, but do not determine provider scores.

"Every number in SaS Stars comes from enterprise clients running these providers in live environments. That changes the starting point completely," said Saurabh Gupta, President, HFS Research. "We are not building another 2X2 matrix for providers to optimize against. We are giving enterprises a decision tool grounded in the experience of their peers, one they can tailor to what matters to them. It also means specialists and challengers can earn visibility through delivery performance, not marketing scale."

Inaugural Agentic AMS ratings expose the gap between AI ambition and production reality

The first SaS Star Ratings study focuses on Agentic Application Management Services (AMS), drawing on more than 400 enterprise client evaluations across 34 providers. The research finds strong enterprise demand but a significant gap between the agentic AMS narrative and what is operating at scale: approximately 54% of enterprise clients expect to increase AMS spending over the next 12 months, yet only around 14% of engagements combine autonomous resolution, AIOps, and live-volume scale. Just 12% use outcome-based, gain-share, or risk-share pricing.

Every SaS Star rating combines two enterprise client verdicts. The star rating reflects how clients score a provider's capabilities as they experience them in delivery across five Services-as-Software towers. It is confidence-adjusted based on how consistently clients agree, and that determines the tier: Leader, Challenger, or Aspirant. Client advocacy—the share who would actively recommend the provider—then positions providers within each tier. Accenture, TCS, Infosys, Capgemini, Publicis Sapient, Cognizant, HCLTech, IBM, and Wipro make up the Leaders tier. No provider earned five stars, which clearly highlights that SaS Stars is not designed to manufacture winners. The data also surfaces strength beyond the largest firms: Challengers Hexaware and Genpact receive the highest scores for Outcome-Aligned Commercials, the lowest-rated tower across every Leader.

The findings suggest the constraint is increasingly commercial and operational rather than purely technical. Enterprise clients report that AI is lowering run costs and improving resolution speed, but fixed-price, capacity-based, and time-and-materials commercial models still dominate.

"Enterprises are automating the work while still paying for effort, and that leaves enterprise clients carrying most of the automation risk. It is the single most important finding in this first study, and it explains why clients rate commercials and delivery consistency as bigger watch-outs than the technology itself," Fersht added.

The research also surfaces a gap between provider marketing and day-to-day client experience. Enterprise clients identified delivery consistency, commercials and pricing, continuity, and scale as more prominent watch-outs than technology capability itself.

The SaS Star ratings include an interactive dashboard built for subscribed enterprise clients making real decisions. The published leaderboard uses the aggregate weighting selected by participating enterprise clients as the study default. Users can adjust any of the five tower sliders to reflect their own priorities and instantly re-rank all 34 providers. An enterprise that puts outcome-aligned commercials first, for example, will see a different shortlist from one that prioritizes AI-first delivery.

The inaugural Agentic AMS edition of HFS SaS Star Ratings is available free to all at https://www.hfsresearch.com/sas-stars/. Future SaS Star Ratings will be available exclusively to HFS premium clients.

About HFS SaS Star Ratings

HFS Services-as-Software (SaS) Star Ratings are provider ratings built entirely from enterprise client evaluations of live provider engagements. HFS designs the methodology and provides research context, but providers have no influence over their scores or ratings: they do not submit scoring inputs, cannot pay to be included or rated, and analysts do not score providers. The ratings help enterprise decision makers compare the providers their peers actually use, understand strengths and watch-outs, adjust criteria to their own priorities, and build evidence-backed shortlists.

About HFS Research

HFS Research is a global research and advisory firm focused on helping enterprise leaders make critical technology and services decisions. HFS combines independent research, enterprise data, and direct engagement with enterprise clients and market leaders to examine how AI, technology, and new operating models are reshaping business outcomes.

SOURCE HFS Research

Share this article

VANCOUVER, BC, Sept. 30, 2026 /PRNewswire/ -- Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) announces that the Company has approved a further variation to the special resolution (the "Amended Articles Resolution") concerning proposed amendments to the Company's Articles to be considered at the Company's annual general and special meeting of shareholders (the "Meeting") to be held on October 2, 2026 at 10:00 a.m. (Pacific time), as further described below. The proxy voting deadline has accordingly been extended to September 30, 2026 at 4:00 p.m. (Pacific time).

As described in the press release issued by the Company on September 22, 2026, the proposed amendments to the Articles include an initial set amendments that, if approved by shareholders, will be implemented immediately following the Meeting. These amendments include proposed amendments to Article 16, which sets forth the process by which shareholders may nominate individuals for election to the Board at a general meeting of shareholders. Among other things, the Company initially proposed to amend Article 16 to limit the amount of information the Company can require a nominating shareholder to provide in order for the Company to assess the independence of the director nominee. Following further deliberation, the Company has determined to amend Article 16 by removing the ability of the Company to request any information with respect to the proposed nominee other than the information specifically enumerated in Article 16, paragraph 4.

A redline showing the proposed amendments to be implemented immediately following the Meeting, including the amendment described, can be found under the Company's profile at www.sedarplus.ca (filed under the heading "Other Securityholder Documents" on September 29, 2026). The full text of the Amended Articles Resolution, as revised to reflect the proposed amendments described above, is set forth below:

"BE IT RESOLVED as a special resolution that:

- The Company be and is hereby authorized and directed to amend the current Articles of the Company in the manner set forth in draft Articles filed with the Canadian Securities Administrators at www.sedarplus.ca on September 29, 2026.

- Subject to the Company determining to list the common shares of the Company on the Main Board of the Hong Kong Stock Exchange (the "Hong Kong Listing"), the Company be and is hereby authorized (but not required) to replace the current Articles of the Company with the Amended Articles as set out in Schedule "1" to the management proxy circular of the Company dated August 12, 2026 (updated to reflect the changes in paragraph 1) concurrently with or shortly before completion of the Hong Kong Listing.

- Any one director or officer of the Company be and is hereby authorized, for and on behalf of the Company, to take all necessary steps and proceedings, including filing of such documents and taking such further actions that may be necessary to effect the amendment to the current Articles; to execute, or cause to be executed, and to deliver or cause to be delivered all such other documents and instruments; and to do or to cause to be done all such other acts and things, as such director or officer the Company may consider to be necessary or desirable to carry out the intent of the foregoing resolutions, such necessity or desirability to be conclusively evidenced by the execution and delivery of any such documents or instruments or the taking of any such actions."

The Board of Directors of the Company recommends that Shareholders vote IN FAVOR of the Amended Articles Resolution, if they have not already done so, ahead of the proxy voting deadline on September 30, 2026 at 4:00 p.m. (Pacific time).

Proxies and voting instructions previously submitted will remain valid. A shareholder who has already voted and wishes to change their vote may submit a new proxy or voting instruction form before the extended deadline by following the instructions in the Circular and the proxy or voting instruction form included therewith. A properly submitted later-dated proxy or voting instruction will replace the shareholder's earlier instructions, provided it is received before the extended voting deadline.

The Company has retained Laurel Hill Advisory Group ("Laurel Hill") to act as its proxy solicitation agent and shareholder engagement manager in connection with the Meeting. Laurel Hill will receive a fee of $30,000 for its services, plus reimbursement of reasonable out-of-pocket expenses. The Company has agreed to indemnify Laurel Hill against certain liabilities arising from its engagement. All costs associated with the solicitation of proxies will be borne by the Company. Proxies may be solicited by mail, telephone, email, internet or other means of communication by Laurel Hill and by directors, officers and employees of the Company.

Shareholder Questions & Assistance

Shareholders who have questions about the Meeting or require assistance voting may contact Laurel Hill toll-free in North America at 1-877-452-7184, by collect call outside North America at 416-304-0211, or by email at [email protected].

About Silvercorp

Silvercorp is a Canadian mining company producing silver, gold, lead, and zinc with a long history of profitability and growth potential. The Company's strategy is to create shareholder value by 1) focusing on generating free cash flow from long-life mines; 2) organic growth through extensive drilling for discovery; 3) ongoing merger and acquisition efforts to unlock value; and 4) long term commitment to responsible mining and ESG. For more information, please visit our website at www.silvercorpmetals.com.

For further information

Silvercorp Metals Inc.

Lon Shaver, President

Phone: (604) 669-9397

Toll Free 1(888) 224-1881

Email: [email protected]

Website: www.silvercorpmetals.com

CAUTIONARY DISCLAIMER - FORWARD-LOOKING STATEMENTS

This news release includes "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable securities laws relating to, among other things, without limitation, statements regarding the Hong Kong Listing and statements regarding the benefits and implementation of the proposed amendments to the Articles. By their very nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking information may in some cases be identified by words such as "will", "anticipates", "expects", "intends" and similar expressions suggesting future events or future performance.

We caution that all forward-looking information is inherently subject to change and uncertainty and that actual results may differ materially from those expressed or implied by the forward-looking information. A number of risks, uncertainties and other factors, including fluctuating commodity prices; recent market events and condition; estimation of mineral resources, mineral reserves and mineralization and metal recovery; interpretations and assumptions of mineral resource and mineral reserve estimates; exploration and development programs; climate change; economic factors affecting the Company; timing, estimated amount, capital and operating expenditures and economic returns of future production; integration of future acquisitions into existing operations; permits and licences for mining and exploration in China; title to properties; non-controlling interest shareholders; acquisition of commercially mineable mineral rights; financing; competition; operations and political conditions; regulatory environment in China; regulatory environment and political climate in Bolivia and Ecuador; integration and operations of Adventus; environmental risks; natural disasters; dependence on management and key personnel; foreign exchange rate fluctuations; insurance; risks and hazards of mining operations; conflicts of interest; internal control over financial reporting as per the requirements of the Sarbanes-Oxley Act; outcome of current or future litigation or regulatory actions; bringing actions and enforcing judgments under U.S. securities laws; cyber-security risks; public health crises; the Company's investment in New Pacific Metals Corp. and Auro Metals Inc.; and the other risk factors described in the Company's latest 40-F/Annual Information Form, and Management's Discussion and Analysis, each under the heading "Risk Factors" available on www.sedarplus.ca and www.sec.gov; could cause actual results and events to differ materially from those expressed or implied in the forward-looking information or could cause our current objectives, strategies and intentions to change. Accordingly, we warn investors to exercise caution when considering statements containing forward-looking information and that it would be unreasonable to rely on such statements as creating legal rights regarding our future results or plans. We cannot guarantee that any forward-looking information will materialize and you are cautioned not to place undue reliance on this forward-looking information. Any forward-looking information contained in this news release represents expectations as of the date of this news release and is subject to change after such date. However, we are under no obligation (and we expressly disclaim any such obligation) to update or alter any statements containing forward-looking information, the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law. All of the forward-looking information in this news release is qualified by the cautionary statements herein.

Company expects skilled trades workforce development investment to exceed $200 million by 2030

BROOKFIELD, Wis., Sept. 30, 2026 /PRNewswire/ -- Milwaukee Tool today announced it has joined the Alliance for America's Skilled Trades, a national effort bringing together companies committed to strengthening the skilled trades workforce and expanding pathways into rewarding careers.

Milwaukee Tool joins the Alliance with a longstanding commitment to the people and organizations building the skilled trades workforce across the United States. For more than 100 years, the company has built its business around serving the professional trades, including investing in workforce development initiatives that support skilled trades education, training and career pathways. Based on investments made since 2010 and those planned through 2030, Milwaukee Tool expects its total investment in U.S. skilled trades workforce development to exceed $200 million.

"Milwaukee Tool has built our business around the skilled trades, and we believe America grows when the trades grow," said Shane Moll, Group President of Milwaukee Tool. "Joining the Alliance gives us another opportunity to build on the work we've been doing alongside the organizations that train and support the next generation of skilled tradespeople. We're proud to bring those relationships, our experience, and our continued investment to this effort."

"When we launched the Alliance, our focus was to help people get the training and support they need to build great careers in the skilled trades," said Lisa Gevelber, Founder of Grow with Google. "Milwaukee Tool has long walked the walk, supporting thousands of apprentices each year and investing deeply in local training centers across the country. Having them join this collective effort allows us to do even more for working people, including expanding access to training and opportunities they can be proud of."

Today, Milwaukee Tool supports more than 16,000 apprentices annually who are actively enrolled in skilled trades programs, working alongside more than 1,300 training centers and 25 national union and non-union partners across the United States.

That work is grounded in longstanding relationships with organizations throughout the skilled trades.

"Developing the next generation of skilled professionals requires a sustained commitment from across our industry. Milwaukee Tool has demonstrated that commitment through its longstanding partnership with MCAA and its direct engagement with the mechanical trades. By listening to the people who perform this work every day and investing in education, training and workforce development, Milwaukee Tool is helping strengthen the skilled trades for the future," said Curtis Harbour, President, Mechanical Contractors Association of America.

"Milwaukee Tool has been a longstanding and valued partner to NECA because they understand that supporting the skilled trades means investing in the people who power our industry," said David Long, CEO of the National Electrical Contractors Association. "Their commitment to listening directly to electrical contractors and the workforce, while continuing to invest in education, training and career pathways, is exactly the kind of sustained industry partnership we need to develop the next generation of skilled professionals."

Through the Alliance for America's Skilled Trades, Milwaukee Tool will work alongside companies and organizations focused on increasing awareness of skilled trades careers, expanding access to training, and helping strengthen the workforce needed to support America's infrastructure and economy.

Milwaukee Tool's commitment to the skilled trades is part of the company's broader investment in the United States. Over the past decade, Milwaukee Tool has invested more than $2 billion in its U.S. operations and added more than 4,000 American jobs in the past five years. All Milwaukee Tool global innovation originates from the company's headquarters in Brookfield, Wisconsin, where the company leads the development of solutions for professional tradespeople around the world. Today, Milwaukee Tool employs more than 11,000 people nationwide and operates 34 facilities across the United States, spanning manufacturing, research and development, engineering, distribution, service and corporate operations.

To learn more about Milwaukee Tool's impact in the United States, visit milwaukeetool.com/company/usa-impact.

About Milwaukee Tool

For over 100 years, Milwaukee Tool has led the industry with innovative solutions that redefine performance, productivity, and safety for the professional trades. Fueled by an unwavering commitment to its users, Milwaukee Tool pioneers breakthrough technologies, products, and services that empower tradespeople to excel in their work and return home safely each day. Milwaukee Tool continues to invest in U.S.-based innovation, workforce development, and advanced manufacturing, alongside its global research, design, and development operations, including major facilities across southeast Wisconsin, Mississippi, Tennessee, Indiana, and Pennsylvania.

Milwaukee® is a subsidiary of Techtronic Industries Co. Ltd. (TTI), a world leader in cordless technology. For more information about Milwaukee Tool, visit www.milwaukeetool.com.  

About the Alliance for America's Skilled Trades

The Alliance for America's Skilled Trades is a coalition of leading American companies committed to closing the nation's skilled trades gap by expanding access to training, apprenticeships, and meaningful career pathways. The Alliance was founded in 2026 and includes members AT&T, Barton Malow, BlackRock, Carhartt, Cintas, DEWALT, Ford Motor Company, Google, The Hershey Company, ManpowerGroup, America's Workforce Academy built by Meta, Microsoft, Milwaukee Tool, and Verizon. 

SOURCE Milwaukee Tool

Share this article

Princeton NuEnergy and SK Battery America Expand Collaboration on U.S. Closed-Loop Battery Recycling

COMMERCE, Ga., Sept. 30, 2026 /PRNewswire/ -- Princeton NuEnergy Inc. (PNE) today announced its ongoing collaboration with SK Battery America (SKBA) to advance the development of a closed-loop recycling pathway for battery manufacturing scrap generated at SKBA's facilities in Commerce, Georgia.

Under the planned collaboration, PNE will receive battery manufacturing scrap from SKBA. The company is exploring a recycling facility near the manufacturing site to develop a streamlined system for battery materials recycling. Designed to process battery manufacturing scrap, the facility would recover and rejuvenate cathode active material for potential return to battery manufacturing, helping support a more integrated domestic battery supply chain.

PNE recently announced that it has been selected by the U.S. Department of Energy to enter award negotiations for up to $50 million in support of a proposed $110 million project to develop a Cathode-to-Cathode® rejuvenation facility in the United States.

Unlike conventional recycling methods that break battery materials down into their constituent elements, PNE's direct recycling process is designed to preserve and rejuvenate the engineered structure of cathode materials.

The collaboration reflects PNE and SKBA's shared interest in improving material circularity, recovering value from battery manufacturing scrap, and strengthening domestic supply chain for critical battery materials. A localized recycling pathway also reduces reliance on imported inputs while supporting U.S. energy security and industrial competitiveness.

PNE and SKBA are continuing discussions regarding the technical and commercial framework for the collaboration.

"Our business collaboration with SK Battery America reflects growing interest in direct recycling solutions for U.S. battery manufacturing," said Chao Yan, Co-Founder and CEO of PNE. "By leveraging PNE's Cathode-to-Cathode® process, we aim to support a more localized and circular domestic battery materials supply chain."

About Princeton NuEnergy, Inc.

Princeton NuEnergy Inc. (PNE) is a U.S.-based advanced battery materials company developing and commercializing proprietary technologies for lithium-ion battery materials production. PNE's platform includes Cathode-to-Cathode® direct recycling for the production of Rejuvenated Cathode Active Material, Advanced Black Mass™ production, and additional battery-material technologies and capabilities in development.

PNE is building a domestic battery materials platform designed to reduce production costs, strengthen critical-mineral security, and support a more resilient U.S. battery supply chain. The company has received strategic and financial support from Honda Motor Co., Ltd., LKQ Corporation, Samsung, Shell Ventures, Traxys, Wistron Corporation, and the U.S. Department of Energy. For more information, visit www.pnecycle.com.

About SK Battery America

SK Battery America, Inc. (SKBA) is a wholly owned subsidiary of SK On and a leading developer and manufacturer of lithium-ion batteries for electric vehicles. SKBA operates electric vehicle battery manufacturing facilities in Commerce, Georgia, with a combined annual production capacity of approximately 22 GWh. The company has invested approximately $2.6 billion in its Commerce operations, supporting the continued growth of the U.S. electric vehicle and battery manufacturing supply chain.

For more information, visit: https://www.skbatteryamerica.com

For media inquiries, please contact:  

Arsalan Khan  

[email protected]  

SOURCE Princeton NuEnergy

Share this article

FRISCO, Texas, Sept. 30, 2026 /PRNewswire/ -- Netwrix, a recognized leader in identity and data security, today released new healthcare findings from its 2026 Data and Identity Security Report. Thirty-one percent of healthcare organizations experienced unauthorized identities accessing sensitive data in the past year, compared with 24% in other industries. Among those that experienced an incident, 33% put the cost above $250,000, compared with 21% in other industries.

Healthcare also ranked lowest among 16 industries for confidence that its Active Directory (AD) environments are free of privilege escalation risks, with 86% lacking full confidence in their Active Directory security. Only 14% of healthcare organizations said they were fully confident, compared with 26% across all industries.

"In healthcare, nobody is starting from a clean slate," said Jeff Warren, Chief Product Officer at Netwrix. "These environments are built on decades of legacy systems, typically underpinned by Active Directory and all the permissions that have accumulated in it. Instead of inheriting the access you meant to give it, an AI agent inherits what's already there."

AI is adding identities faster than healthcare can govern them

Seventy-nine percent of healthcare organizations said their non-human identities are not fully governed. Seventy-five percent said AI and automation have increased identity-related risk to sensitive data over the past two years, and 70% said their data access governance is behind the speed of AI adoption.

Most healthcare organizations can't immediately see who has access

Seventy-seven percent can't immediately determine who has access to a specific piece of sensitive data, a challenge that AI is likely to exacerbate as agents proliferate. Sixty-one percent said it would take hours and multiple tools. Forty-eight percent said a compromised identity is the most common starting point for unauthorized access to sensitive data.

An account with limited permissions in Active Directory can still have a route to more sensitive resources through relationships such as delegation and group membership. Permissions that are no longer needed can make those paths harder to identify. Netwrix PingCastle assesses Active Directory environments for security risks and provides remediation guidance.

"Before adding more AI agents and other non-human identities, healthcare organizations need to understand the access that's already there," said Darryl Baker, Senior Staff Security Researcher at Netwrix. "An account can appear to be pretty limited and still have a route to something much more sensitive. Proactively discovering privilege escalation paths and cleaning up permissions give you a much clearer view of what you're handing to a new identity."

Methodology

The Netwrix 2026 Data and Identity Security Report is based on a global survey of 2,317 security professionals conducted in early 2026. The research benchmarked 1,889 organizations across more than 60 industries and 12 security dimensions.

The healthcare findings are based on 145 healthcare respondents, primarily in the United States. Sixteen industries had sufficient representation for industry-level comparisons. Healthcare responses were compared with responses from other industries where noted.

Additional Resources

Download the Netwrix 2026 Data and Identity Security Report

Assess Active Directory security risks with Netwrix PingCastle

Data, Identity & AI Security Assessment: A free benchmarking tool that evaluates organizations across 12 security dimensions and five maturity tiers for AI readiness.

About Netwrix

Netwrix's vision is to create a world where every organization has secured its data and identities. The 1Secure™ platform unifies identity and data security to provide complete visibility into where data lives, who can access it, and how it's governed. With Netwrix, security teams strengthen data protection, safeguard identities, and stay ahead of evolving threats. Today, more than 13,000 customers, including nearly 25% of the Fortune 500, rely on Netwrix solutions across hybrid and AI-driven environments. With a 95% customer satisfaction rating, Netwrix offers flexible delivery models that are quick to deploy, easy to use, and built to scale for organizations of all sizes.

Media Contacts:

Natalie Reina

Director of Public Relations, Netwrix

[email protected]

SOURCE Netwrix

Share this article